Wellington Biomedical Innovation Master Investors (Cayman) II L.P. - 30 Jan 2025 Form 3 Insider Report for Metsera, Inc. (MTSR)

Role
10%+ Owner
Signature
Wellington Biomedical Innovation Master Investors (Cayman) II L.P., By: Wellington Management Company LLP, as Investment Adviser, /s/ Peter N. McIsaac, Authorized Person
Issuer symbol
MTSR
Transactions as of
30 Jan 2025
Net transactions value
$0
Form type
3
Filing time
30 Jan 2025, 20:46:24 UTC
Previous filing
15 Oct 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding MTSR Series B Preferred Stock 30 Jan 2025 Common Stock 1,857,699 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share of Series B Preferred Stock is convertible into Common Stock on a 2.349723-for-1 basis at the option of the holder, and will convert automatically upon closing of the Issuer's initial public offering into the number of shares shown in column 3 without payment of consideration. The Series B Preferred Stock has no expiration date.